The company has a clear philosophy of driving its strategy and direction for the global opportunity for well-produced, branded, high quality, safe and effective medicinal and wellbeing products to effect real change in people’s lives. Our interlectual capital is creating a portfolio of related IP assets that meet clear commercial needs which offer our shareholders best-in-class returns.
CGI PLC’s long-term aim is to develop Intellectual Property that can be licensed out to Pharmaceutical companies capable of bringing revolutionary cannabis-based drugs to market. We are building a diversified portfolio of cannabis-focused IP assets across brands, products, stains, and medical & process patents.
Drawing on the specialist expertise, skills and proven corporate governance of the Board of Directors and global network of partnerships, CGI PLC is well placed to begin generating revenue in early 2020. We perform our research in partnership with specialist third parties such as third party labs, universities, hospitals, and where possible governments.
Canna Global Investments PLC (CGI PLC) is an agricultural biotechnology, investment and brands company with an extreme Impact Investing Ecosystem ethos. We focus on researching, developing, investing in and licensing sustainable medical cannabis and hemp products and their derived intellectual property. Our clients will have the confidence in knowing that our products will be free of harmful chemicals, metals, bacterial pathogens and microbiological contaminants. CGI PLC has a management team with deep expertise across R&D, product development, cannabis investing verticals, technology, sales and finance. Our ultimate vision is to create material shareholder value while advancing cannabanoid research & development or cheaper sustainable drugs.
Medical marijuana: Fastest growing industry in USA with $7 out of $10 spent on it.
Cannabis Europa: Focus on entry to the UK cannabis market though Africa.